Reply to: MIDN locus structural variants and Parkinson's disease risk

Ann Clin Transl Neurol. 2020 Apr;7(4):604-605. doi: 10.1002/acn3.51011. Epub 2020 Mar 22.

Authors

Yutaro Obara¹, Hidenori Sato², Takahiro Nakayama³, Takeo Kato⁴, Kuniaki Ishii¹

Affiliations

¹ Department of Pharmacology, Yamagata University School of Medicine, Yamagata, Japan.
² Genome Informatics Unit, Institution for Promotion of Medical Science Research, Yamagata University School of Medicine, Yamagata, Japan.
³ Research Institute of Bio-system informatics, Tohoku Chemical Co., LTD, Morioka, Japan.
⁴ Yamagata City Institute of Public Health, Yamagata, Japan.

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Living Donors
Nuclear Proteins
Parkinson Disease*
Risk Factors

Substances

Nuclear Proteins
midnolin